{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:02:57Z","timestamp":1791655377529,"version":"4.3.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To describe perivascular flower-bud-like lesions (PFBLs) as novel characteristics of vitreoretinal lymphoma on en face optical coherence tomography (OCT) angiography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective chart review was performed on 23 consecutive patients (35 eyes), who had biopsy-proven vitreoretinal lymphoma between January 2018 and March 2021. En face OCT angiography images were analyzed before and after intervention. PFBLs were initially identified on midretinal slabs of en face OCT angiography, and were further characterized by other imaging modalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Perivascular flower-bud-like lesions were detected in 12 eyes (34.3%) of 8 patients, of which 8 eyes had best-corrected visual acuity of 20\/40 or better. In 10 of the 12 eyes, PFBLs were detected within 6 months of symptom onset. On en face OCT angiography, PFBLs presented as punctate points or confluent bands surrounding retinal vessels, with arterial and venous involvement. In 4 of the 12 eyes, arteries were mainly affected. On OCT B-scans, PFBLs commonly appeared as hyperreflective full-thickness intraretinal lesions that colocalized with subretinal pigment epithelium deposits (3 eyes, 25%) and retinal pigment epithelium irregularities (4 eyes, 33.3%). However, PFBLs could not always be identified on other imaging modalities such as fundus photographs and fundus fluorescein angiography. In all eyes with follow-up, PFBLs attenuated or resolved months after receiving chemotherapy or diagnostic vitrectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PFBLs are characteristic imaging findings of vitreoretinal lymphoma and may facilitate an early diagnosis of vitreoretinal lymphoma, which would in turn lead to more timely and effective treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000003579","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:01:29Z","timestamp":1660867289000},"page":"2169-2175","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["PERIVASCULAR FLOWER-BUD-LIKE LESIONS ON EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH VITREORETINAL LYMPHOMA"],"prefix":"10.1097","volume":"42","author":[{"given":"Wenwen","family":"Chen","sequence":"first","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China;"},{"name":"NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China;"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiang","family":"Gu","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China;"},{"name":"NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China;"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixue","family":"Liu","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China;"},{"name":"NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China;"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Kellogg eye center, university of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China;"},{"name":"NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China;"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezhi","family":"Xu","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China;"},{"name":"NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China;"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China;"},{"name":"NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China;"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/bjophthalmol-2017-311612","article-title":"Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis","volume":"102","author":"Barry","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/ceo.13668","article-title":"Intraocular chemotherapy for vitreoretinal lymphoma: a review","volume":"48","author":"Kvopka","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40942-018-0120-4","article-title":"The diagnosis and treatment of primary vitreoretinal lymphoma: a review","volume":"4","author":"Pulido","year":"2018","journal-title":"Int J Retina Vitreous"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00417-016-3395-x","article-title":"Optical coherence tomography manifestations of primary vitreoretinal lymphoma","volume":"254","author":"Saito","year":"2016","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajo.2021.11.023","article-title":"Advanced OCT analysis of biopsy-proven vitreoretinal lymphoma","volume":"238","author":"Pichi","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/IAE.0000000000002819","article-title":"Spectral domain optical coherence tomography features of vitreoretinal lymphoma in 55 eyes","volume":"41","author":"Yang","year":"2021","journal-title":"Retina"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/ICU.0000000000000620","article-title":"Primary vitreoretinal lymphoma: empowering our clinical suspicion","volume":"30","author":"Takhar","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/blood-2015-01-620518","article-title":"High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates","volume":"126","author":"Bonzheim","year":"2015","journal-title":"Blood"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ophtha.2020.01.042","article-title":"Logistic regression classification of primary vitreoretinal lymphoma versus uveitis by interleukin 6 and interleukin 10 levels","volume":"127","author":"Kuo","year":"2020","journal-title":"Ophthalmology"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajo.2021.09.032","article-title":"Vitreoretinal lymphoma: optimizing diagnostic yield and accuracy","volume":"236","author":"Santos","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1097\/IAE.0000000000003241","article-title":"Clinical features, diagnostic significance, and prognosis of vitreoretinal lymphoma in young patients","volume":"41","author":"Liu","year":"2021","journal-title":"Retina"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12886-019-1300-1","article-title":"Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaophthalmol.2018.5835","article-title":"Vertical hyperreflective lesions on optical coherence tomography in vitreoretinal lymphoma","volume":"137","author":"De\u00e1k","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.3928\/23258160-20181002-26","article-title":"En face optical coherence tomography angiography of primary vitreoretinal lymphoma","volume":"49","author":"Pierro","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0039-6257(94)90158-9","article-title":"Intraocular lymphoma presenting as retinal vasculitis","volume":"39","author":"Brown","year":"1994","journal-title":"Surv Ophthalmol"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.critrevonc.2017.03.019","article-title":"Primary central nervous system lymphoma","volume":"113","author":"Citterio","year":"2017","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T14:04:04Z","timestamp":1749305044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003579","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}